020 8877 3482 | business@metainsights.ai

WE ARE AN AI-POWERED RESEARCH SERVICE, SPECIALISING IN BIOPHARMA ASSET EVALUATION, DELIVERING THE KEY INTELLIGENCE YOU NEED TO HELP YOU MAKE THE RIGHT INVESTMENT DECISIONS WITH CONFIDENCE.

Learn more
HOW WE HELP

ARMING YOU WITH THE INTELLIGENCE YOU NEED

Investors need robust knowledge when making decisions around biopharma assets, as a thorough opportunity evaluation is essential in order to minimize risks and maximize returns. A comprehensive approach ensures informed decision-making and positions investments to capitalize on high-value opportunities in a dynamic healthcare market.

Key business questions can include the following:

  • How have the treatment landscape and competitor market share changed?
  • How have similar products performed (adoption, market penetration)?
  • How have market drivers and barriers previously affected similar products?
  • What are the historical market trends and growth rates for the therapeutic area?
  • What are the clinical and commercial outcomes for products with similar TPPs?

metAInsights™ answers all these questions - and more - based on validated responses from thousands of verified HCPs and patients.

Scroll Down
WHAT WE DO

TRANSFORMING BIOPHARMA INVESTMENT DECISION-MAKING

TRADITIONAL ASSET EVALUATION METHODS HAVE BENEFITS, BUT THEY ALSO HAVE THEIR CHALLENGES:

Syndicated Reporting

Syndicated Reporting

  • Broad coverage
  • Standardised data
  • Generic insight
  • Lacks customisation
KOL Input

KOL Input

  • Expert knowledge
  • Tailored insights
  • Prone to bias
  • Limited scope
Primary Research

Primary Research

  • Very customisable
  • Up-to-date insights
  • Time-consuming
  • Very high cost

For pharma and biotech investment teams, metAInsights™ is the superior choice.

metAInsights™ offers customized, in-depth analysis using insights from real KOLs, empowering investors to make the right decisions around high-potential opportunities.

Scroll Down
OUR SERVICE

POWERING YOUR DECISIONS WITH AI AND HUMAN THINKING

Created to leverage a vast library of human-generated qualitative biopharma insights, metAInsights™ is designed to help you make smarter investment decisions.

Using state-of-the-art large language models (LLMs), metAInsights™, guided by our expert team, combines 10 years of global pharma asset development studies to bring you the insights you need to make the right investment decisions.

Leverage Unique insights
Access answers from 100,000 verified respondents.
Explore insights from a unique, propriety dataset.
Harness 10+ years of data worth over £230 million.
Power
Decision-Making
Validate your decision-making in just days.
Enhance your sample with more respondents.
Action custom, validated, reliable intelligence.
Accelerate Vital Research
Supplement in-depth interviews with data-backed research.
Get an initial steer on your your thinking in just hours.
Reduce hassle through reliable, trustworthy outputs.
Scroll Down